高级检索
当前位置: 首页 > 详情页

Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究负责人:
研究单位: [1]Ipsen [2]Chengdu Women's and Children's Central Hospital Chengdu,China,610073 [3]Jiangxi Provincial Children's Hospital Nanchang,China,330006 [4]Children's Hospital of Nanjing Nanjing,China,210008 [5]Tangshan Maternal & Child Health Hospital Tangshan,China,063000 [6]Tongji Hospital,Tongji Medical College,Huazhong University of Science & Technology Wuhan,China,430030 [7]Wuxi Children's Hospital Wuxi,China,214023 [8]Henan Children's Hospital,Zhengzhou Children's Hospital Zhengzhou,China,450018

研究目的:
The purpose of this study is to observe whether the Triptorelin pamoate 15mg (3-month formulation) effectiveness in Chinese population of CPP children has the same or similar trend with that in overseas CPP population. This is measured by assessing the proportion of children who have a suppressed Luteinizing Hormone (LH) response to Gonadotropin Releasing Hormone (GnRH) test performed 3 months after injection of triptorelin.

资源点击量:428 今日访问量:0 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)